LIQUIDIA CORPORATION (LQDA) Pre-Tax Margin
- 2026-06-30: Pre-Tax Margin 47.59%.
- 2026-03-31: Pre-Tax Margin 42.74%.
- 2025-06-30: Pre-Tax Margin -470.51%.
- 2025-03-31: Pre-Tax Margin -1229.71%.
Complete source-backed pre-tax margin history.
- Available history
- 2025-03-31 to 2026-06-30
- Data captured
Historical Pre-Tax Margin
| Date | Pre-Tax Margin |
|---|---|
| 2026-06-30 | 47.59% |
| 2026-03-31 | 42.74% |
| 2025-06-30 | -470.51% |
| 2025-03-31 | -1229.71% |
Annual Pre-Tax Margin
| Date | Pre-Tax Margin |
|---|
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |